“are any major causes emerging yet for the increase in less than one year recoveries and reduction in severe LC cases?”
Not sure if I understand your question, but: it looks like people who got LC from a reinfection were getting assigned as if they had LC since their first infection, which messed up the recovery data.
I still don’t know why new cases are less likely and less severe, probably a combination of: fewer susceptible people, significant protection from vaccines and previous infection, and a longer time since certain viruses were prevalent that led to an imprinted response. That is, the immune systems of people who develop Long Covid seem to often have responded by making antibodies against other coronaviruses rather than making entirely new and specific antibodies.
And when over the next few years would you expect the numbers to grow significantly, as a rough estimate?
6-12 months maybe? I don’t know. Vaccinations are dropping in Western countries. I don’t think we’ll see a similar growth rate as we saw on the
LDN: funding for a trial just got announced. It won’t be a game changer, but seems like it helps some people somewhat (and a lucky few benefit a lot)
Life satisfaction: not aware of great studies. It’s pretty bad, though maybe not as bad as ME/CFS. I’m especially worried about people in low income countries, which we hear next to nothing about
“are any major causes emerging yet for the increase in less than one year recoveries and reduction in severe LC cases?” Not sure if I understand your question, but: it looks like people who got LC from a reinfection were getting assigned as if they had LC since their first infection, which messed up the recovery data.
I still don’t know why new cases are less likely and less severe, probably a combination of: fewer susceptible people, significant protection from vaccines and previous infection, and a longer time since certain viruses were prevalent that led to an imprinted response. That is, the immune systems of people who develop Long Covid seem to often have responded by making antibodies against other coronaviruses rather than making entirely new and specific antibodies.
And when over the next few years would you expect the numbers to grow significantly, as a rough estimate? 6-12 months maybe? I don’t know. Vaccinations are dropping in Western countries. I don’t think we’ll see a similar growth rate as we saw on the
LDN: funding for a trial just got announced. It won’t be a game changer, but seems like it helps some people somewhat (and a lucky few benefit a lot)
Life satisfaction: not aware of great studies. It’s pretty bad, though maybe not as bad as ME/CFS. I’m especially worried about people in low income countries, which we hear next to nothing about